Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2022-11-21Clinical Trial Update: Virtual Reality Job Interview Training in Severe Mental Illness [NA]
A completed clinical trial evaluating virtual reality job interview training for individuals with severe mental illness, including schizophr…
-
FDA approval · 2022-11-18FDA Approved: HALOPERIDOL — Original Application (Novadoz Pharmaceuticals LLC)
FDA approves the original application for HALOPERIDOL, a generic product manufactured by Novadoz Pharmaceuticals LLC.
-
FDA approval · 2022-10-27FDA Approved: ARIPIPRAZOLE — Original Application (Advagen Pharma Ltd)
FDA approves Advagen Pharma Ltd's original application for a generic aripiprazole product.
-
FDA approval · 2022-10-25FDA Approved: RISPERIDONE — Supplemental Application (Solco Healthcare US, LLC)
The FDA approved a supplemental application for risperidone submitted by Solco Healthcare US, LLC.
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: Pentoxifylline as an Adjunctive in Treatment of Negative Symptoms in Chronic Schizophrenia [Phase 1, Phase 2]
Clinical trial updates report studying pentoxifylline as an adjunctive treatment for negative symptoms in chronic schizophrenia (Phase 1/Pha…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: Group Cognitive-behavioral Intervention for Social Anxiety in Schizophrenia [Phase 1, Phase 2]
This clinical trial update reports on a group cognitive-behavioral intervention for social anxiety in individuals with schizophrenia, coveri…
-
FDA approval · 2022-10-25FDA Approved: ARIPIPRAZOLE — Original Application (Chartwell RX, LLC)
The FDA approved Chartwell RX, LLC's original application for a generic aripiprazole product. Aripiprazole is used to treat schizophrenia, b…
-
FDA approval · 2022-10-24FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Original Application (Upsher-Smith Laboratories,LLC)
FDA approves Upsher-Smith's generic fluphenazine hydrochloride under an Original Abbreviated New Drug Application (ANDA).
-
CLINICAL_TRIALS trial_result · 2022-10-18Clinical Trial Update: A Study of LY2140023 in Patients With Schizophrenia [Phase 3]
Phase 3 clinical trial update for LY2140023 in schizophrenia; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: Families With Substance Use and Psychosis: A Pilot Study [NA]
A completed pilot study from McLean Hospital investigating families with substance use and psychosis; results posted in 2022.
-
FDA approval · 2022-10-06FDA Approved: LURASIDONE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental abbreviated new drug application for lurasidone hydrochloride, enabling marketing of the ge…
-
CLINICAL_TRIALS trial_result · 2022-10-04Clinical Trial Update: A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia [Phase 3]
Phase 3 trial completed evaluating TV-46000 for maintenance treatment in schizophrenia; results posted.
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: Targeted Self-Management for Epilepsy and Serious Mental Illness (TIME) [NA]
Completed clinical trial TIME studied targeted self-management for epilepsy and serious mental illness; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-09-22Clinical Trial Update: Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life Randomized Control Trial [NA]
Completed randomized trial assessing the impact of physical activity on health outcomes in schizophrenia-spectrum disorders; results posted …
-
FDA approval · 2022-09-20FDA Approved: ARIPIPRAZOLE — Supplemental Application (Dr.Reddys Laboratories Inc)
FDA approved a supplemental application for ARIPIPRAZOLE by Dr. Reddy's Laboratories Inc. under the ANDA, authorizing a modification to the …
-
FDA approval · 2022-09-15FDA Approved: ZIPRASIDONE MESYLATE — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved the original Abbreviated New Drug Application for ziprasidone mesylate from Novadoz Pharmaceuticals LLC, a generic version of z…
-
FDA approval · 2022-09-09FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (MAJOR PHARMACEUTICALS)
FDA approves Major Pharmaceuticals' original application for lurasidone hydrochloride (generic).
-
CLINICAL_TRIALS trial_result · 2022-09-07Clinical Trial Update: A Comparison Study of LY2140023 and Aripiprazole in Schizophrenia Patients [Phase 3]
Phase 3 trial comparing LY2140023 with aripiprazole in schizophrenia was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-09-06Clinical Trial Update: Cannabidiol Treatment in Patients With Early Psychosis [Phase 2]
Phase 2 trial of cannabidiol for early psychosis completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-09-06Clinical Trial Update: Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy [Phase 4]
A Phase 4 clinical trial update assessing disturbance of plasma cytokine parameters in clozapine-resistant, treatment-refractory schizophren…
-
CLINICAL_TRIALS trial_result · 2022-09-01Clinical Trial Update: A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients [Phase 2]
A Phase 2 safety trial comparing LY2140023 to standard atypical antipsychotic treatment in schizophrenia has completed with posted results.
-
FDA approval · 2022-08-29FDA Approved: PERSERIS — Supplemental Application (Indivior Inc.)
The FDA approved a supplemental application for PERSERIS (risperidone) from Indivior Inc., indicating a modification to the product’s approv…
-
CLINICAL_TRIALS trial_result · 2022-08-29Clinical Trial Update: Alpha-lipoic Acid Adjunctive Therapy in Schizophrenia [Phase 2, Phase 3]
Phase 2/3 trial investigating alpha-lipoic acid as adjunctive therapy for schizophrenia with a focus on oxidative stress, completed.
-
FDA approval · 2022-08-24FDA Approved: QUETIAPINE — Original Application (Solco Healthcare US, LLC)
FDA approves Solco Healthcare's original application for a generic quetiapine product (quetiapine fumarate tablets), enabling a generic vers…
-
CLINICAL_TRIALS trial_result · 2022-08-23Clinical Trial Update: Carnosine and Cognitive Training in Schizophrenia [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating the combination of carnosine and cognitive training in schizophrenia has been completed.